Objectives: Venous outflow stenosis secondary to intimal hyperplasia is a common cause of dialysis access failure. Currently, treatment with angioplasty and stenting has high rates of reintervention. We evaluated the efficacy of drug-eluting balloons (DEB) on the treatment of venous outflow stenosis of arteriovenous fistulas and grafts.
Objectives: Venous outflow stenosis secondary to intimal hyperplasia is a common cause of dialysis access failure. Currently, treatment with angioplasty and stenting has high rates of reintervention. We evaluated the efficacy of drug-eluting balloons (DEB) on the treatment of venous outflow stenosis of arteriovenous fistulas and grafts.
Methods: We prospectively followed 13 patients on hemodialysis whose dialysis access had been treated with Bard Lutonix DEB (Paclitaxel) for venous outflow stenosis. Patients were not randomized, and treatments were at the discretion of the treating physician. Postinterventional follow-up consisted of clinic visits and routine duplex ultrasound imaging. Primary end points were time to reintervention and patency of target lesion.
Results: All 13 patients had venous outflow stenosis diagnosed by duplex ultrasound imaging. Eight patients had brachiocephalic fistulas (AVFs), while the other five had grafts (AVGs). All patients underwent balloon angioplasty with DEB of the venous outflow stenosis. There was a mean follow-up of 10 months. Two patients died of unrelated events during the follow-up period. Of the 11 remaining patients, six (56%) were intervention free. Of those that require reintervention, two underwent angioplasty for central venous stenosis unrelated to the initial site of DEB angioplasty. Taking this into account eight (73%) of the AVFs/ AVGs whose venous outflow were treated with DEB were patent at 10 months. Only three patients required repeat angioplasty at the initial site of DEB angioplasty.
Conclusions: Our study suggests favorable results for the treatment of venous outflow stenosis in arteriovenous fistulas and grafts with DEB however larger prospective studies are warranted prior to making a definitive recommendation.
Author Disclosures: E. Galiñanes: Nothing to disclose; C. Jayanetti: Nothing to disclose; S. Kang: Nothing to disclose; J. Pereda: Nothing to disclose. Objectives: Dialysis access-associated steal syndrome (DASS) is a complication of arteriovenous fistula (AVF) dialysis access creation whereby significant flow reduction distal to the fistula results in clinically significant hand ischemia. After obtaining consent, we describe a patient with of steal phenomenon who was treated using a novel, entirely endovascular technique.
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A Completely Endovascular Technique for the Treatment of Dialysis-Associated Steal Syndrome
Methods: An 82-year-old woman with past medical history significant for end-stage renal disease on hemodialysis, coronary artery bypass grafting (1996) , and diabetes mellitus presented with severe right arm rest pain following access placement. On examination, there was swelling, limited motion, and clear ischemia with gangrene developing at the tip of her right third finger. A right upper extremity angiogram revealed a patent brachial artery, brachiocephalic fistula, and arterial anastomosis with no evidence of obstruction. Continuous flow was demonstrated beyond the anastomosis into the antecubital brachial artery with twovessel runoff into the hand. The next day, the patient underwent intragraft partial stent grafting of the anastomosis. In the operating room, left common femoral access was obtained. On angiogram, a majority of the injected dye migrated into the fistula, indicating clearly the presence of high-flow steal syndrome. A 6-mm-Â 1.6-cm-long covered stent was deployed into the middle of the anastomosis under ultrasound guidance. Forward flow was still not visualized. An additional stent graft was placed, such that three-quarters of the length of the anastomosis was covered. Forward flow remained suboptimal, but with noticeable improvement in ischemic signs. The catheters and wires were removed. Despite visible improvement, it was unsure whether this procedure would alleviate her symptoms.
Results: There were no complications during the procedure. At the 1-month follow-up, marked reduction in steal was noted, and the hand lesions were healing. Over the following year, the patient presented four times for recurrent right central venous stenosis, treated each time venoplasty and eventually stenting. The recurrent venous stenosis was unrelated to the endovascular access revision. She also suffered an acute middle cerebral artery infarct during this time period. The access was consistently viable and repeatedly used during this time. There was no recurrence of DASS, and she eventually died of unrelated causes 1 year and 3 months after treatment.
Conclusions: We present a patient with severe DASS complicated by digital gangrene, which was successfully treated endovascularly using intragraft partial stent grafting of the anastomosis. This novel method enabled a high-risk patient to avoid open surgery, preserve her limb, and preserve the function of her AV access.
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Modified Banding of Fistulas for Steal Syndrome With Quantitative Data
Vikalp Jain, Yana Etkin, Gregg Landis. Northwell Health Physician Partners, New Hyde Park, NY Objectives: Steal syndrome is a rare complication of arteriovenous fistula (AVF) creation, which is difficult to manage. There are several treatment modalities described in the literature. The most common of these include banding, distal revascularization with interval ligation (DRIL) procedures, proximalization of arterial inflow (PAI), and revision using distal inflow (RUDI) procedures. Although all of these procedures have been shown to work, the long-term success rate is limited by failure to treat steal or loss of access. One of the major limitations of all of these techniques is the lack of quantitative data that is gathered during the procedure to ensure success of treatment. We propose a modified method for AVF banding that incorporates measurements of distal arterial pressure to improve the success of this procedure.
Methods: Over a period of 12 months between November 2015 and November 2016, four patients with brachiocephalic fistulas presented with steal syndrome as evidenced by nonhealing wounds on their digits. All of these patients were brought to the operating room and had an operative exposure of their fistula at the level of their anastomosis. An arterial catheter was placed through the fistula into the distal arterial system to obtain an arterial pressure. Next, a band of polytetrafluoroethylene was place around the vein and was constricted until the distal arterial pressure was raised to a systolic pressure >100 mm Hg or within 20 mm Hg of the baseline systolic blood pressure in the contralateral arm if the systolic pressure was <100 mm Hg.
Results: A thrill was present in all the fistulas at the end of the procedure. At the 1-month follow-up, all ischemic hand wounds were noted to heal, and all fistulas remained patent and were successfully being used for dialysis.
Conclusions: The use of quantitative data to assess successful treatment of steal syndrome is possible and will likely result in improved outcomes. Further research with a larger number of patients is necessary to establish an ideal pressure goal.
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